Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites...
Moderate or Severe Liver Disease893 (1.22%)352 (0.45%) Metastatic Carcinoma2100 (2.87%)1663 (2.12%) HIV/AIDS0 (0.00%)0 (0.00%) How to get help Look at the help files for details and examples of almost every function in this package. There are several vignettes showing the main features...
(See Section I.A.6. "Etiology/manifestations") ( ) Parentheses are used in both the index and tabular to enclose supplementary words that may be present or absent in the statement of a disease or procedure without affecting the code number to which it is ICD-9-CM Official Guidelines for ...
Older adults can experience vision impairment following stroke in combination with pre-existing ophthalmologic disease. The new ICD-10 coding system for identifying vision related health conditions provides a much higher level of detail for coding these complex scenarios than the previous ICD-9 system....
The SAPS II includes only 17 variables: 12 physiology variables, age, type of admission (scheduled surgical, unscheduled surgical, or medical), and three underlying disease variables (acquired immunodeficiency syndrome, metastatic cancer, and hematologic malignancy). Goodness-of-fit tests indicated that...
a phase II study focusing on metastatic pancreatic cancer treated with tarextumab, a fully human IgG2 antibody that inhibits Notch2/3 receptors, in combination with gemcitabine (GEM) and paclitaxel, showed remarkable remission and tolerance among patients, indicating a promising future for therapies...
Moderate or Severe Liver Disease 893 (1.22%) 352 (0.45%) Metastatic Carcinoma 2100 (2.87%) 1663 (2.12%) HIV/AIDS 0 (0.00%) 0 (0.00%) How to get help Look at the help files for details and examples of almost every function in this package. There are several vignettes showing the mai...
Moderate or Severe Liver Disease 893 (1.22%) 352 (0.45%) Metastatic Carcinoma 2100 (2.87%) 1663 (2.12%) HIV/AIDS 0 (0.00%) 0 (0.00%) How to get help Look at the help files for details and examples of almost every function in this package. There are several vignettes showing the mai...
We investigated the p75 Neurotrophin Receptor (p75NTR) expression and cleavage product p75NTR Intracellular Domain (p75ICD) as potential oncogenic and metastatic markers in human Laryngeal Squamous Cell Carcinoma (LSCC). p75NTR is highly expressed in Cancer Stem Cells (CSCs) of the laryngeal epithelia...